Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Intervenciones para la prevención y el tratamiento de la enfermedad hepática avanzada en la fibrosis quística

Esta versión no es la más reciente

ver la versión actual 30 marzo 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD012056.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 29 agosto 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Senthil K Palaniappan

    Department of Medicine, University Hospitals of Leicester, NHS trust, Leicester, UK

  • Nan Nitra Than

    Correspondencia a: Department of Community Medicine, Faculty of Medicine, Melaka, Malaysia

    [email protected]

  • Aung Win Thein

    Department of Surgery, Melaka‐Manipal Medical College, Melaka, Malaysia

  • Soe Moe

    Department of Community Medicine, Faculty of Medicine, Melaka, Malaysia

  • Indra van Mourik

    Liver Unit, Birmingham Children's Hospital, Birmingham, UK

Contributions of authors

Roles and responsibilities

Task

Who will undertake the task?

Protocol stage: draft the protocol

SK, SM, NNT, IVM, AWT

Review stage: select which trials to include (2 + 1 arbiter)

SK, NNT, AWT

Review stage: extract data from trials (2 people)

SK, SM

Review stage: enter data into RevMan

SK, IVM, NNT

Review stage: carry out the analysis

SK, SM, NNT, AWT

Review stage: interpret the analysis

SK, SM, IVM, AWT

Review stage: draft the final review

SK, NNT, IVM, AWT

Update stage: update the review

SK, SM, NNT, IVM, AWT

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Institute for Health Research, UK.

    This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Declarations of interest

All authors: none known.

Acknowledgements

We would like to take this opportunity to express our gratitude to Mrs Nikki Jahnke, Managing Editor at the Cochrane Cystic Fibrosis and Genetic Disorders (CFGD) Group who supported us throughout this work. We are thankful for her inspiring guidance, and friendly advice on writing the protocol. We would also like to express our warm thanks to Professor Datuk Abdul Razzak, Chief Executive of Melaka Manipal Medical College and Professor Jaspal Singh Sahota, Dean of Melaka Manipal Medical College for their support in writing this protocol and review.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2020 Mar 30

Interventions for preventing and managing advanced liver disease in cystic fibrosis

Review

Senthil K Palaniappan, Nan Nitra Than, Aung Win Thein, Indra van Mourik

https://doi.org/10.1002/14651858.CD012056.pub3

2017 Aug 29

Interventions for preventing and managing advanced liver disease in cystic fibrosis

Review

Senthil K Palaniappan, Nan Nitra Than, Aung Win Thein, Soe Moe, Indra van Mourik

https://doi.org/10.1002/14651858.CD012056.pub2

2016 Jan 27

Interventions for managing advanced liver disease in cystic fibrosis

Protocol

Senthil K Palaniappan, Nan Nitra Than, Soe Moe, Indra van Mourik, Aung Win Thein

https://doi.org/10.1002/14651858.CD012056

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Figure 1 PRISMA study flow diagram
Figuras y tablas -
Figure 1

Figure 1 PRISMA study flow diagram

Ir a la figura de la revisiónAbrir en una pestaña nueva